The treatment for liver most cancers depends on the stage of the condition. The study aimed to guage the efficacy of low dose capecitabine combined with sorafenib in subset of Egyptian HCV patients presented with advanced HCC unfit for surgical or locoregional therapies. Sorafenib-induced hepatitis is characterized by a hepatocellular pattern of liver damage with important increases of transaminases.We estimated …
Sorafenib For Treating Advanced Hepatocellular Carcinoma

Commentaires récents